New ACMG Carrier Screening Guidelines Could Improve Equity of Lab Results
Gary J. Latham, PhD
The updated guidelines significantly expand the number of genes recommended for screening pregnant women
Gary J. Latham, PhD
Gary J. Latham, PhD, is the chief scientific officer at Asuragen, a Bio-Techne brand. The opinions expressed here are his own and not necessarily those of the organization.